Pearl River Capital’s Acceleron Pharma XLRN Stock Holding History

Pearl River Capital’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,789	Closed	-$996K	–	615
2021 Q3	$996K	Buy	+5,789	New	+$757K	0.27%	123

Pearl River Capital's XLRN Position: Q4 2021 in Review

Pearl River Capital sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 5,789 shares — an estimated $996K sold.

Pearl River Capital first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $996K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Pearl River Capital reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Pearl River Capital sold 5,789 Acceleron Pharma shares in Q4 2021, an estimated $996K.
Pearl River Capital first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Pearl River Capital's Acceleron Pharma position peaked at $996K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Pearl River Capital's 13F filing for Q4 2021, filed 11 Feb 2022.